Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Tobacco Alternative Gums
... at a CAGR of 6.0% over the analysis period 2024-2030. 2 mg, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$3.5 Billion by the end of ... Read More
-
Human Papillomavirus (HPV) Testing
... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Hospitals & Clinics, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$919.4 Million by ... Read More
-
Idiopathic Pulmonary Fibrosis
... at a CAGR of 5.7% over the analysis period 2024-2030. PIRFENIDONE, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$4.8 Billion by the end of the ... Read More
-
Infectious Disease Diagnostics
... at a CAGR of 5.5% over the analysis period 2024-2030. Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion by the end ... Read More
-
Infertility Treatment
... CAGR of 7.5% over the analysis period 2024-2030. Equipment, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$1.3 Billion by the end of the analysis period. ... Read More
-
Interventional Neurology Devices
... at a CAGR of 4.6% over the analysis period 2024-2030. Cerebral Embolization & Aneurysm Coiling, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$2.0 Billion by ... Read More
-
Diabetic Macular Edema Treatment
... 2030, growing at a CAGR of 2.2% over the analysis period 2024-2030. Anti-VEGF, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$2.7 Billion by the end ... Read More
-
Male Hypogonadism
... CAGR of 5.1% over the analysis period 2024-2030. Testosterone Replacement Therapy, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.5 Billion by the end of the ... Read More
-
Bone Cement and Glue
... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Arthroplasty, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.0 Billion by the end ... Read More
-
Cardiovascular Ultrasound Systems
... at a CAGR of 5.1% over the analysis period 2024-2030. 2D, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.1 Billion by the end of the ... Read More
-
Shoulder Arthroplasty
... CAGR of 4.1% over the analysis period 2024-2030. Partial, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.2 Billion by the end of the analysis period. ... Read More
-
Neuroprosthetics
... 11.9% over the analysis period 2024-2030. Spinal Cord Stimulation, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$11.7 Billion by the end of the analysis period. ... Read More
-
Online Sex Toys
... at a CAGR of 6.8% over the analysis period 2024-2030. Adult Vibrators, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$9.5 Billion by the end of ... Read More
-
Ophthalmic Femtosecond Lasers
... at a CAGR of 4.6% over the analysis period 2024-2030. Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$666.4 Million by the end ... Read More
-
Brain Tumor Diagnosis and Treatment
... Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Primary Brain Tumor, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.3 ... Read More
-
NDDS in Cancer Therapy
... 2030, growing at a CAGR of 20.7% over the analysis period 2024-2030. Nanoparticles, one of the segments analyzed in the report, is expected to record a 20.6% CAGR and reach US$67.8 Billion by the end ... Read More
-
Spinal Muscular Atrophy
... at a CAGR of 12.3% over the analysis period 2024-2030. Type 1, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$2.4 Billion by the end of ... Read More
-
Brain Computer Interface
... at a CAGR of 10.3% over the analysis period 2024-2030. Invasive BCI, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$1.5 Billion by the end of ... Read More
-
Constipation Treatment
... CAGR of 5.9% over the analysis period 2024-2030. Laxatives, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$12.3 Billion by the end of the analysis period. ... Read More
-
Cryptococcosis Treatment
... CAGR of 4.5% over the analysis period 2024-2030. Amphotericin B, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$5.5 Billion by the end of the analysis ... Read More
-
Genitourinary Drugs
... CAGR of 2.3% over the analysis period 2024-2030. Urologicals, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$10.7 Billion by the end of the analysis period. ... Read More
-
Hyperpigmentation Disorders Treatment
... at a CAGR of 5.9% over the analysis period 2024-2030. Topical Drugs, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$3.3 Billion by the end of ... Read More
-
Neuroprotection Therapeutics
... CAGR of 6.9% over the analysis period 2024-2030. Free Radical Trapping Agents (Antioxidants), one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$45.7 Billion by the end ... Read More
-
Orthopedic Braces & Support, Casting and Splints
... expected to reach US$10.1 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Orthopedic Braces & Supports, one of the segments analyzed in the report, is expected to record a ... Read More
-
Rheumatology Therapeutics
... CAGR of 3.2% over the analysis period 2024-2030. Disease Modifying Anti-Rheumatic Drugs (DMARDs), one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$51.3 Billion by the end ... Read More
Research Assistance
